Pine Harbor Wealth Management’s AbbVie ABBV Stock Holding History

Pine Harbor Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Sell	1,536 -18	-1%	-$3.87K	0.1%	72
2026 Q1	$338K	Buy	1,554 +2	+0.1%	+$444	0.1%	73
2025 Q4	$355K	Buy	1,552 +66	+4%	+$15K	0.11%	71
2025 Q3	$344K	Sell	1,486 -53	-3%	-$10.8K	0.11%	74
2025 Q2	$286K	Buy	1,539 +3	+0.2%	+$558	0.1%	80
2025 Q1	$322K	Buy	1,536 +11	+0.7%	+$2.14K	0.13%	65
2024 Q4	$271K	Sell	1,525 -185	-11%	-$34K	0.11%	78
2024 Q3	$338K	Buy	1,710 +15	+0.9%	+$2.8K	0.17%	69
2024 Q2	$291K	Buy	1,695 +189	+13%	+$31.3K	0.17%	73
2024 Q1	$274K	Sell	1,506 -118	-7%	-$20.3K	0.17%	72
2023 Q4	$252K	Buy	+1,624	New	+$237K	0.19%	79

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pine Harbor Wealth Management's ABBV Position: Q2 2026 in Review

Pine Harbor Wealth Management reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $3.87K and leaving 1,536 shares worth $387K. The position accounts for 0.1% of the portfolio, ranked #72.

Pine Harbor Wealth Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pine Harbor Wealth Management held 1,536 shares of AbbVie worth $387K as of Q2 2026.
Pine Harbor Wealth Management sold 18 AbbVie shares in Q2 2026, an estimated $3.87K.
AbbVie made up 0.1% of Pine Harbor Wealth Management's portfolio in Q2 2026, its #72 holding.
Pine Harbor Wealth Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pine Harbor Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.